Globucel® (General Information)
Globucel® contains human immunoglobulins, also known as intravenous immunoglobulins (IVIg). It is manufactured through fractionation of large volumes of plasma pooled from healthy Indian donors. Globucel® is used to provide passive immunity by increasing an individual's antibody titer and antigen-antibody reaction potential. Because of this property, Globucel® remains efficacious and safer treatment option for various diseases of auto-immune origin or immunodeficiency states.
INDICATION
- Guillain-Barre syndrome
- Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
- Primary Immunodeficiency (PID) Syndromes
- Secondary Immunodeficiency (SID) Syndromes
- Kawasaki Syndrome
- Idiopathic Thrombocytopenic Purpura
- Allogeneic bone marrow transplantation
CONTRAINDICATION
Globucel is contraindicated in individuals who have had anaphylactic or severe systemic reactions to immunoglobulin or any ingredients in the formulation. Epinephrine should be available for immediate treatment of an anaphylactic reaction if it occurs.
Globucel® is contraindicated in individuals with selective IgA deficiency or IgA deficiency with antibodies against IgA, since these individuals may have antibodies to IgA (or develop antibodies following administration of Globucel®) or other blood products containing IgA.
Acute hypersensitivity reaction to corn; this product contains maltose derived from corn.
STORAGE
- Store between 2°c to 8°c.
- Do not administer after more than 4 hours of opening the container and any remnant portions to be discarded since solution does not contain preservative.
- Do not freeze. Do not use if the solution is turbid or any particulate matters observed.
- Keep out of reach and sight of children.
- Store in the original container to protect from light.
